Latest for Mixed Connective Tissue Disease
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
- Trial sites45 new sites opened for Pan-tumor MRD Study (Paradigm Health)ClinicalTrials.gov
More about Mixed Connective Tissue Disease
Progressive sclerosis of skin occurs, particularly affecting hands and forearms (sclerodactyly), developing in most patients over time. Myositis with elevated muscle enzymes (CK, aldolase) and objective muscle weakness develops in variable proportions of patients. Lung involvement is common. In a nationwide Norwegian study, 52% of patients had abnormal lung CT scans and 19% had severe lung scarring (fibrosis). Pulmonary hypertension was found in 3.4% of patients, fewer than older studies reported, but it is a serious complication.
Keep reading about Mixed Connective Tissue Disease
Esophageal dysmotility and renal involvement occur though less frequent than in classic scleroderma or SLE. Unlike SLE, MCTD typically demonstrates lower rates of glomerulonephritis and CNS involvement. Disease course varies from mild stable disease to progressive multi-organ involvement. Serial monitoring of pulmonary function and cardiac status is critical for detecting progressive disease and intervening early.
What are the symptoms of Mixed Connective Tissue Disease?
These are common symptoms of Mixed Connective Tissue Disease, and how strong they are varies from person to person.
- Raynaud phenomenon
- Hand edema and sclerodactyly
- Myalgia and arthritis
- Photosensitivity and rashes
- Dysphagia and esophageal dysfunction
- Pulmonary fibrosis in advanced disease
Who gets Mixed Connective Tissue Disease?
Typically presents in women ages 20-50 with female predominance, about 3.3 women for every man in a nationwide Norwegian study. NORD notes a much higher reported prevalence in some countries, notably Japan. Can occur at any age from childhood to elderly though adult onset most typical.
Diagnosis often delayed 3-5 years from symptom onset due to overlapping clinical features. Geographic and ethnic variations in prevalence reported. Rare familial clustering reported without clear genetic inheritance pattern. Disease activity and organ involvement severity vary considerably among affected individuals.
Next steps: find trials you might fitsee what is being testedget help payingget alerts
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Mixed Connective Tissue Disease
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Mixed Connective Tissue Disease resources
Reputable organizations and medical references for learning more about Mixed Connective Tissue Disease, including disease registries, foundation resources, and clinical guidelines.
- NIH GARD - Mixed Connective Tissue Disease
- American College of Rheumatology
- NORD - Mixed Connective Tissue Disease
- Gunnarsson R et al. The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients. Ann Rheum Dis 2011
- Gunnarsson R et al. Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study. Ann Rheum Dis 2012
- Gunnarsson R et al. Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort. Rheumatology (Oxford) 2013